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I2 receptors (I2-IR) are widely distributed in the central nervous system. I2-IR ligands are 
associated with a neuroprotective effect but, as I2-IR structure remains unknown, the 
discovery of better and more selective ligands is necessary to understand the pharmacological 
and molecular implications of I2-IR.  
Recently, we described a new imidazoline-structure family which showed high affinity and 
selectivity for I2-IR. In vivo studies in mice indicated a neuroprotective role and revealed 
beneficial effects in behaviour and cognition with a murine model of neurodegeneration, 
senescence-accelerated prone mouse (SAMP8).  
Herein, we report a novel non-imidazoline-structure of bicyclic α-iminophosphonates family 
with high affinities for I2-IR. In vivo studies in 5X-FAD mice (a transgenic representative model 
of AD) and SAMP8 mice (a model of neurodegeneration linked to aging) showed an 
improvement in behaviour and cognition, a reduction of AD hallmarks and of 
neuroinflammation markers for the mice treated with the lead compound B06. After 
evaluating several pathways associated with neurodegeneration, we demonstrated that CaN 
pathway plays a critical role on the neuroprotective effects of I2-IR ligands on SAMP8 mice 
model.  
To rule out warnings of the novel family, we calculated DMPK and physicochemical properties 
for the novel bicyclic α-iminophosphonates. As well, we carried out drug metabolism, safety 
studies and in vivo pharmacokinetics for lead compound B06.  
In summary, we present a novel family of I2-IR ligands, its effectiveness in in vivo models and 
the possible neuroprotective molecular mechanism mediated by them. This highlights that the 
modulation of I2-IR by bicyclic α-iminophosphonates may open a new therapeutic venue for 
unmet neurodegenerative conditions. 
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